Viewing StudyNCT06461819

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-07-17 @ 11:33 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06461819
Status: RECRUITING
Last Update Posted: 2024-06-21
First Post: 2024-06-11
Brief Title: Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-intermediate Risk Localized Prostate Cancer DESAR-L
Sponsor: Samsung Medical Center
Organization: Samsung Medical Center
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Low-to-intermediate-risk Prostate Carcinoma
Keywords: